B3 S.A.:企業の戦略・SWOT・財務分析

◆英語タイトル:B3 S.A. - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY3260
◆発行会社(調査会社):MarketLine
◆発行日:2019年11月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ブラジル
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

B3 S.A. – Strategy, SWOT and Corporate Finance Report
Summary

B3 S.A. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

B3 S.A. (B3), formerly BM&FBOVESPA S.A.-Bolsa de Valores, Mercadorias e Futuros, is a securities, commodities and futures exchange. It provides financial market infrastructure for trading on exchange and OTC environment. The company creates and manages trading systems; and conducts settlement, clearing, deposit and registration, and other post-trade services for several securities classes. B3 offers trading products such as equities, securities, financial assets, indices, agricultural commodities and spot contracts. It provides electronic and online trading systems, clearing and settlement, lending and listing of securities, central depository of securities, financial market information solutions, indices, connectivity solutions, and technological infrastructure, among others. It also offers vehicle and real estate lending solutions. The company operates in Brazil, the US, the UK and China. B3 is headquartered in Sao Paulo, Brazil.

Scope

- Detailed information on B3 S.A. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting B3 S.A. in the form of a SWOT analysis
- An in-depth view of the business model of B3 S.A. including a breakdown and examination of key business segments
- Intelligence on B3 S.A.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about B3 S.A., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of B3 S.A. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess B3 S.A. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on B3 S.A.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
B3 S.A.: Company Overview
B3 S.A.: Overview and Key Facts
B3 S.A.: Overview
B3 S.A.: Key Facts
B3 S.A.: Key Employees
B3 S.A.: Key Employee Biographies
B3 S.A.: Major Products and Services
B3 S.A.: Company History
B3 S.A.: Management Statement
B3 S.A.: Locations and Subsidiaries
B3 S.A.: Key Competitors
B3 S.A.: Company Analysis
B3 S.A.: Business Description
B3 S.A.: SWOT Analysis
B3 S.A.: SWOT Overview
B3 S.A.: Strengths
B3 S.A.: Weaknesses
B3 S.A.: Opportunities
B3 S.A.: Threats
B3 S.A.: Corporate Financial Deals Activity
B3 S.A.: Financial Deals Overview
B3 S.A.: Targets and Partners
B3 S.A.: Top Deals 2015 – 2019YTD*
B3 S.A.: Advisors
B3 S.A.: Top Legal Advisors
B3 S.A.: Mergers and Acquisitions
B3 S.A.: Corporate Venturing
B3 S.A.: Recent Developments
B3 S.A.: News and Events Summary
B3 S.A.: Financial Deals
B3 S.A.: Financial Performance
B3 S.A.: Regulatory and Legal Events
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: B3 S.A.: Key Facts
Table 2: B3 S.A.: Key Employees
Table 3: B3 S.A.: Company History
Table 4: B3 S.A.: Locations and Subsidiaries
Table 5: B3 S.A.: Key Competitors
Table 6: B3 S.A.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: B3 S.A.: M&A Activity by Geography (TTM*)
Table 8: B3 S.A.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 9: B3 S.A.: M&A Average Deal Size - Value (US$m)
Table 10: B3 S.A.: Targets and Partners
Table 11: B3 S.A.: Top Deals 2015 - 2019YTD*
Table 12: B3 S.A.: Legal Advisor Ranking by Value (US$m)
Table 13: B3 S.A.: M&A Volume and Value Trend (2015 - YTD*2019)
Table 14: B3 S.A.: M&A Activity by Geography (2015 - YTD*2019)
Table 15: B3 S.A.: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Table 16: B3 S.A.: Corporate Venturing by Geography (2015 - YTD*2019)
Table 17: B3 S.A.: News and Events Summary
Table 18: B3 S.A.: Financial Deals
Table 19: B3 S.A.: Financial Performance
Table 20: B3 S.A.: Regulatory and Legal Events

★海外企業調査レポート[B3 S.A.:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • METRO Retail Stores Group Inc (MRSGI):企業の財務・戦略的SWOT分析
    METRO Retail Stores Group Inc (MRSGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Kone Corporation
    Kone Corporation - Strategy, SWOT and Corporate Finance Report Summary Kone Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Twist Bioscience Corp (TWST):製薬・医療:M&Aディール及び事業提携情報
    Summary Twist Bioscience Corp (Twist Bioscience) is a provider of synthetic DNA Tools. Its silicon-based DNA synthesis platform enables precise synthesis and sequencing process and production of synthetic DNA tools. The company offers its products which include DNA tools for gRNA cloning such as una …
  • Old Dominion Electric Cooperative:企業の戦略的SWOT分析
    Old Dominion Electric Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Group Five Limited (GRF):企業の財務・戦略的SWOT分析
    Group Five Limited (GRF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Amarin Corp Plc (AMRN):企業の財務・戦略的SWOT分析
    Amarin Corp Plc (AMRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Genetic Analysis AS:製薬・医療:M&Aディール及び事業提携情報
    Summary Genetic Analysis AS (Genetic Analysis) is a molecular diagnostic company that mapping of microbiota by utilizing the GA-map technology to develop IVD tests in various diseases. The company develops gene-based routine tests for the mapping and diagnosis of diseases related to dysbiosis and ba …
  • Syndax Pharmaceuticals Inc (SNDX):企業の財務・戦略的SWOT分析
    Summary Syndax Pharmaceuticals Inc (Syndax) is a biopharmaceutical company that develops and commercializes therapies for multiple cancer indications. The company’s lead product candidate includes entinostat, an oral, small molecule drug candidate, which is in phase 3 clinical trial used for the tre …
  • ResApp Health Ltd (RAP):企業の製品パイプライン分析
    Summary ResApp Health Ltd (ResApp) formerly, Narhex Life Sciences Limited is a digital health company that develops smartphone applications for the diagnosis and management of respiratory disease. It's digital healthcare solutions assist doctors and patients to diagnose and manage respiratory diseas …
  • Advanced BioScience Laboratories Inc-製薬・医療分野:企業M&A・提携分析
    Summary Advanced BioScience Laboratories Inc (ABL), a subsidiary of Institut Merieux SA is a contract research and manufacturing company that provides services to life sciences industry. The company develops vaccines, therapeutics and other biologic products. It provides proof-of-concept in vivo stu …
  • Alfa Wassermann SpA-製薬・医療分野:企業M&A・提携分析
    Summary Alfa Wassermann SpA (Alfa Wassermann), a subsidiary of AlfaSigma SpA is a pharmaceutical company which produces and distributes drugs for human health. The company provides new discoveries in medicine, biology and genomics. Alfa Wassermann finds solutions for paradox treatment. The company o …
  • U.S. Neurosurgical Inc (USNU):企業の財務・戦略的SWOT分析
    Summary U.S. NeuroSurgical Inc (USN) is a medical service company that provides biotechnology and neurosurgery services. The company assists and facilitates medical device manufacturers in gaining access and entry into the US neurosurgical marketplace. It provides treatment services such as gamma kn …
  • Luna Innovations Inc (LUNA)-医療機器分野:企業M&A・提携分析
    Summary Luna Innovations Inc (Luna) is a optical technology development company that research, develops and commercializes speed optics and fiber optic test products. The company’s products include fiber optic sensing products, fiber optic test and measurement products, high speed optical products, …
  • Hexicon AB:電力:M&Aディール及び事業提携情報
    Summary Hexicon AB (Hexicon) is a design and engineering company that manufactures and develops floating multi-platforms for offshore wind energy production. The company offers utilities to the developers for managing and utilizing the power of offshore wind and Hexicon platforms, and provides tank …
  • Bruker Daltonics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Bruker Daltonics Inc (Bruker Daltonics), a subsidiary of Bruker Corp, is a medical device company that manufactures scientific instruments for molecular and materials research, and for industrial and applied analysis. The company's products include mass spectrometry and separations, preclini …
  • Manitoba Hydro-Electric Board:発電所・企業SWOT分析
    Manitoba Hydro-Electric Board - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • ERM Power Ltd:企業の戦略的SWOT分析
    ERM Power Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Kalvista Pharmaceuticals Inc (KALV):医療機器:M&Aディール及び事業提携情報
    Summary Kalvista Pharmaceuticals Inc (Kalvista), formerly Carbylan Therapeutics Inc, is a pharmaceutical company that discovers, develops and commercializes small molecule protease inhibitors. The company’s product candidates are inhibitors of plasma kallikrein, which is being developed for heredita …
  • Mesoblast Ltd (MSB):企業の財務・戦略的SWOT分析
    Mesoblast Ltd (MSB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • BrightPath Biotherapeutics Co Ltd (4594):製薬・医療:M&Aディール及び事業提携情報
    Summary BrightPath Biotherapeutics Co Ltd (BrightPath Biotherapeutics), formerly GreenPeptide Co Ltd is a biopharmaceutical company that develops novel cancer immunotherapies. The company offers drug discovery research and early clinical development of cancer immunotherapy; early-phase clinical tria …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆